125 related articles for article (PubMed ID: 28625317)
21. Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia-reperfusion: role of TSPO and STAR.
Bréhat J; Leick S; Musman J; Su JB; Eychenne N; Giton F; Rivard M; Barel LA; Tropeano C; Vitarelli F; Caccia C; Leoni V; Ghaleh B; Pons S; Morin D
Basic Res Cardiol; 2024 Jun; 119(3):481-503. PubMed ID: 38517482
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial Kinase Signaling for Cardioprotection.
Boengler K; Eickelmann C; Kleinbongard P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674076
[TBL] [Abstract][Full Text] [Related]
23. Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia-Reperfusion Injury Using a Dual-Locking Mitochondrial Targeting Strategy.
Yin J; Zheng X; Zhao Y; Shen X; Cheng T; Shao X; Jing X; Huang S; Lin W
Angew Chem Int Ed Engl; 2024 May; 63(21):e202402537. PubMed ID: 38509827
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: A review.
Yan Z; Xing Z; Xue T; Zhao J; Li G; Xu L; Sun Q
Medicine (Baltimore); 2024 Mar; 103(9):e37279. PubMed ID: 38428899
[TBL] [Abstract][Full Text] [Related]
25. FAM3A As a Potential Molecular Target to Regulate Mitochondrial Respiration and ATP Production in Ischemic Heart.
Hu Y
J Cardiovasc Transl Res; 2024 Feb; 17(1):102-103. PubMed ID: 37668896
[No Abstract] [Full Text] [Related]
26. Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions.
Patel SH; Wilson GC; Wu Y; Keitsch S; Wilker B; Mattarei A; Ahmad SA; Szabo I; Gulbins E
J Mol Med (Berl); 2024 May; ():. PubMed ID: 38780771
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of KMO Ameliorates Myocardial Ischemia Injury via Maintaining Mitochondrial Fusion and Fission Balance.
Lai Q; Wu L; Dong S; Zhu X; Fan Z; Kou J; Liu F; Yu B; Li F
Int J Biol Sci; 2023; 19(10):3077-3098. PubMed ID: 37416768
[TBL] [Abstract][Full Text] [Related]
28. Phospholipids, the Masters in the Shadows during Healing after Acute Myocardial Infarction.
Pistritu DV; Vasiliniuc AC; Vasiliu A; Visinescu EF; Visoiu IE; Vizdei S; Martínez Anghel P; Tanca A; Bucur O; Liehn EA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176067
[TBL] [Abstract][Full Text] [Related]
29. The Role of Hydrogel in Cardiac Repair and Regeneration for Myocardial Infarction: Recent Advances and Future Perspectives.
Li P; Hu J; Wang J; Zhang J; Wang L; Zhang C
Bioengineering (Basel); 2023 Jan; 10(2):. PubMed ID: 36829659
[TBL] [Abstract][Full Text] [Related]
30. Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization.
Zhang H; Chen Y; Li F; Wu C; Cai W; Ye H; Su H; He M; Yang L; Wang X; Zhou K; Ni W
J Neuroinflammation; 2023 Jan; 20(1):6. PubMed ID: 36609266
[TBL] [Abstract][Full Text] [Related]
31. A ROS-Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro-Angiogenesis for Efficient Treatment of Myocardial Infarction.
Zheng Z; Lei C; Liu H; Jiang M; Zhou Z; Zhao Y; Yu CY; Wei H
Adv Healthc Mater; 2022 Oct; 11(19):e2200990. PubMed ID: 35848825
[TBL] [Abstract][Full Text] [Related]
32. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction.
Kuang Y; Li X; Liu X; Wei L; Chen X; Liu J; Zhuang T; Pi J; Wang Y; Zhu C; Gong X; Hu H; Yu Z; Li J; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
Cardiovasc Res; 2021 Jan; 117(2):585-599. PubMed ID: 32091582
[TBL] [Abstract][Full Text] [Related]
34. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.
Heusch G
Nat Rev Cardiol; 2020 Dec; 17(12):773-789. PubMed ID: 32620851
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease.
Gaggini M; Fenizia S; Vassalle C
Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237968
[TBL] [Abstract][Full Text] [Related]
36. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease.
Guo J; Feng J; Qu H; Xu H; Zhou H
J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547431
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y
Maslov LN; Popov SV; Mukhomedzyanov AV; Derkachev IA; Ryabov VV; Boshchenko AA; Prasad NR; Sufianova GZ; Khlestkina MS; Gareev I
Korean Circ J; 2022 Oct; 52(10):737-754. PubMed ID: 36217596
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid metabolism and signaling in cardiovascular diseases.
Borodzicz-Jażdżyk S; Jażdżyk P; Łysik W; Cudnoch-Jȩdrzejewska A; Czarzasta K
Front Cardiovasc Med; 2022; 9():915961. PubMed ID: 36119733
[TBL] [Abstract][Full Text] [Related]
39. Circ-RHOJ.1 regulated myocardial cell proliferation and apoptosis via targeting the miR-124-3p/NRG-1 axis in myocardial ischemia/reperfusion injury.
Liu Y; Ke X; Guo W; Wang X; Peng C; Liao Z; Liu Q; Zhou Y
Arch Med Sci; 2022; 18(3):732-745. PubMed ID: 35591844
[TBL] [Abstract][Full Text] [Related]
40. Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms.
Maslov LN; Popov SV; Mukhomedzyanov AV; Naryzhnaya NV; Voronkov NS; Ryabov VV; Boshchenko AA; Khaliulin I; Prasad NR; Fu F; Pei JM; Logvinov SV; Oeltgen PR
Curr Cardiol Rev; 2022; 18(5):63-79. PubMed ID: 35422224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
